Table 1 Patient and tumour characteristics

From: A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer

No. of patients 36
Median age (range) 62 years (36–82)
Gender  
 Male 27
 Female 9
ECOG performance status
 0 15
 1 18
 2 3
Clinical staging  
 T2 4
 T3 26
 T4 5
 n.a. 1
 cN 0 4
 cN + 31
 n.a. 1
Distant metastases
 Resectable (liver) 2
 Supected (pleura, irresectable) 1
Distance from lower tumour margin to anal verge
 Median 5 cm
 Range 2–15 cm
 0–5 cm 21
 >5–10 cm 9
 >10 cm 5
 NA 1